DenovAI Biotech
Dynamic Protein Design
Active
Seed
Startup
Rehovot
Founded 2023-01
DenovAI is developing foundational technology platforms that can design proteins de novo - completely from scratch. The company is starting the journey to design next generation therapeutics like high-affinity antibodies, small protein and peptide biologics, and diagnostic reporters - all tailored to bind to their specific targets. Its AI-based platform for…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$4.0M
Employees11
Founded2023-01
HQRehovot
Confidence80
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Artificial IntelligenceBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology